1,173 results on '"Chen, Minhu"'
Search Results
2. Assessment of Endoscopy-Based Scoring Systems for Prognostication in Ulcerative Colitis: A Comparative Analysis
3. Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn’s disease development
4. Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis
5. Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort
6. Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn’s disease: A prospective animal model and human cohort study
7. Deep learning model to differentiate Crohn’s disease from intestinal tuberculosis using histopathological whole slide images from intestinal specimens
8. The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial
9. AI-based fingerprint index of visceral adipose tissue for the prediction of bowel damage in patients with Crohn’s disease
10. Decoding polyphenol metabolism in patients with Crohn’s disease: Insights from diet, gut microbiota, and metabolites
11. Platelet-to-lymphocyte percentage ratio for assessing disease activity and predicting therapeutic outcomes in ulcerative colitis
12. Validation of disease severity index for predicting complicated disease in Crohn's disease: A comparison study with Lémann index
13. Predicting Factors of Long-term Outcome of Gastrointestinal Behçet's Disease: A Chinese Retrospective Study
14. Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cells
15. Bacteroides uniformis ameliorates pro-inflammatory diet-exacerbated colitis by targeting endoplasmic reticulum stress-mediated ferroptosis
16. Epithelial Nlrp10 inflammasome mediates protection against intestinal autoinflammation
17. Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease
18. Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
19. Blocking Dectin-1 prevents colorectal tumorigenesis by suppressing prostaglandin E2 production in myeloid-derived suppressor cells and enhancing IL-22 binding protein expression
20. Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
21. Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study
22. Intestinal fibrosis classification in patients with Crohn’s disease using CT enterography–based deep learning: comparisons with radiomics and radiologists
23. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association
24. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: a multicentre cohort study
25. The Role of Colchicine in Different Clinical Phenotypes of Behcet Disease
26. Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial
27. Dietary inflammatory potential mediated gut microbiota and metabolite alterations in Crohn's disease: A fire-new perspective
28. Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
29. Microbial Assimilatory Sulfate Reduction-Mediated H2S: An Overlooked Role in Crohn's Disease Development
30. Index-Based Dietary Patterns and Inflammatory Bowel Disease: A Systematic Review of Observational Studies
31. DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease
32. Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors.
33. Microbial assimilatory sulfate reduction-mediated H2S: an overlooked role in Crohn's disease development.
34. Long-term outcomes and associated factors of Crohn's disease patients achieving transmural healing based on magnetic resonance enterography: a Chinese retrospective cohort study.
35. Pharmacokinetics, Safety, and Tolerability of Tenapanor in Healthy Chinese and Caucasian Volunteers: A Randomized, Open-Label, Single-Center, Placebo-Controlled Phase 1 Study
36. Milk fat globule-epidermal growth factor 8 (MFGE8) prevents intestinal fibrosis
37. Myeloid-derived suppressor cells in gastroenteropancreatic neuroendocrine neoplasms
38. Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
39. Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
40. Intracolic ultrasound molecular imaging: a novel method for assessing colonic tumor necrosis factor-α expression in inflammatory bowel disease
41. Precision medicine in IBD: genes, drugs, bugs and omics
42. Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study.
43. Schaumann bodies deposited along myenteric plexus of the muscularis propria is a unique histopathological feature of Crohn’s disease
44. International clinical practice guideline on the use of traditional Chinese medicine for ulcerative colitis by Board of Specialty Committee of Digestive System Disease of World Federation of Chinese Medicine Societies (2023)
45. Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors
46. Validation of disease severity index for predicting complicated disease in Crohn's disease: A comparison study with Lémann index
47. Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
48. S288 Clinical Effectiveness of Vedolizumab in Chinese Ulcerative Colitis Patients: Results From the VALUE Study
49. S287 Clinical Effectiveness of Vedolizumab in Chinese Crohn's Disease Patients: Results From the VALUE Study
50. S593 First Interim Analysis of Safety and Effectiveness in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study of Vonoprazan in Real-World Clinical Practice in China
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.